Clinical Trial: Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: An Open Label Exploratory Study to Assess the Safety, Tolerability and Clinical Activity of Topically Applied ESBA105 in Patients With Acute Anterior Uveitis

Brief Summary: The purpose of this study is to determine whether ESBA105, a topically applied TNF-alpha inhibitor, is safe and clinically active when applied to the eye of patients suffering from acute anterior uveitis